List of Tables
Table 1. Global Overactive Bladder Diagnosis and Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Overactive Bladder Diagnosis and Treatment Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Overactive Bladder Diagnosis and Treatment Market Competitive Situation by Manufacturers in 2024
Table 4. Global Overactive Bladder Diagnosis and Treatment Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Overactive Bladder Diagnosis and Treatment Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Overactive Bladder Diagnosis and Treatment Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Overactive Bladder Diagnosis and Treatment Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Overactive Bladder Diagnosis and Treatment Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Overactive Bladder Diagnosis and Treatment, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Overactive Bladder Diagnosis and Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Overactive Bladder Diagnosis and Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Overactive Bladder Diagnosis and Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Overactive Bladder Diagnosis and Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Overactive Bladder Diagnosis and Treatment as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Overactive Bladder Diagnosis and Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Overactive Bladder Diagnosis and Treatment Sales by Region (2020-2025) & (K Units)
Table 18. Global Overactive Bladder Diagnosis and Treatment Sales Market Share by Region (2020-2025)
Table 19. Global Overactive Bladder Diagnosis and Treatment Sales by Region (2026-2031) & (K Units)
Table 20. Global Overactive Bladder Diagnosis and Treatment Sales Market Share by Region (2026-2031)
Table 21. Global Overactive Bladder Diagnosis and Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Overactive Bladder Diagnosis and Treatment Revenue Market Share by Region (2020-2025)
Table 23. Global Overactive Bladder Diagnosis and Treatment Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Overactive Bladder Diagnosis and Treatment Revenue Market Share by Region (2026-2031)
Table 25. North America Overactive Bladder Diagnosis and Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Overactive Bladder Diagnosis and Treatment Sales by Country (2020-2025) & (K Units)
Table 27. North America Overactive Bladder Diagnosis and Treatment Sales by Country (2026-2031) & (K Units)
Table 28. North America Overactive Bladder Diagnosis and Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Overactive Bladder Diagnosis and Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Overactive Bladder Diagnosis and Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Overactive Bladder Diagnosis and Treatment Sales by Country (2020-2025) & (K Units)
Table 32. Europe Overactive Bladder Diagnosis and Treatment Sales by Country (2026-2031) & (K Units)
Table 33. Europe Overactive Bladder Diagnosis and Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Overactive Bladder Diagnosis and Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Overactive Bladder Diagnosis and Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Overactive Bladder Diagnosis and Treatment Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Overactive Bladder Diagnosis and Treatment Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Overactive Bladder Diagnosis and Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Overactive Bladder Diagnosis and Treatment Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Overactive Bladder Diagnosis and Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Overactive Bladder Diagnosis and Treatment Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Overactive Bladder Diagnosis and Treatment Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Overactive Bladder Diagnosis and Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Overactive Bladder Diagnosis and Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Overactive Bladder Diagnosis and Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Overactive Bladder Diagnosis and Treatment Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Overactive Bladder Diagnosis and Treatment Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Overactive Bladder Diagnosis and Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Overactive Bladder Diagnosis and Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Overactive Bladder Diagnosis and Treatment Sales (K Units) by Type (2020-2025)
Table 51. Global Overactive Bladder Diagnosis and Treatment Sales (K Units) by Type (2026-2031)
Table 52. Global Overactive Bladder Diagnosis and Treatment Sales Market Share by Type (2020-2025)
Table 53. Global Overactive Bladder Diagnosis and Treatment Sales Market Share by Type (2026-2031)
Table 54. Global Overactive Bladder Diagnosis and Treatment Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Overactive Bladder Diagnosis and Treatment Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Overactive Bladder Diagnosis and Treatment Revenue Market Share by Type (2020-2025)
Table 57. Global Overactive Bladder Diagnosis and Treatment Revenue Market Share by Type (2026-2031)
Table 58. Global Overactive Bladder Diagnosis and Treatment Price (US$/Unit) by Type (2020-2025)
Table 59. Global Overactive Bladder Diagnosis and Treatment Price (US$/Unit) by Type (2026-2031)
Table 60. Global Overactive Bladder Diagnosis and Treatment Sales (K Units) by Application (2020-2025)
Table 61. Global Overactive Bladder Diagnosis and Treatment Sales (K Units) by Application (2026-2031)
Table 62. Global Overactive Bladder Diagnosis and Treatment Sales Market Share by Application (2020-2025)
Table 63. Global Overactive Bladder Diagnosis and Treatment Sales Market Share by Application (2026-2031)
Table 64. Global Overactive Bladder Diagnosis and Treatment Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Overactive Bladder Diagnosis and Treatment Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Overactive Bladder Diagnosis and Treatment Revenue Market Share by Application (2020-2025)
Table 67. Global Overactive Bladder Diagnosis and Treatment Revenue Market Share by Application (2026-2031)
Table 68. Global Overactive Bladder Diagnosis and Treatment Price (US$/Unit) by Application (2020-2025)
Table 69. Global Overactive Bladder Diagnosis and Treatment Price (US$/Unit) by Application (2026-2031)
Table 70. Astellas Pharma Inc Company Information
Table 71. Astellas Pharma Inc Description and Business Overview
Table 72. Astellas Pharma Inc Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Astellas Pharma Inc Overactive Bladder Diagnosis and Treatment Product
Table 74. Astellas Pharma Inc Recent Developments/Updates
Table 75. Teva Pharmaceutical Industries Company Information
Table 76. Teva Pharmaceutical Industries Description and Business Overview
Table 77. Teva Pharmaceutical Industries Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Teva Pharmaceutical Industries Overactive Bladder Diagnosis and Treatment Product
Table 79. Teva Pharmaceutical Industries Recent Developments/Updates
Table 80. Pfizer Inc Company Information
Table 81. Pfizer Inc Description and Business Overview
Table 82. Pfizer Inc Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Pfizer Inc Overactive Bladder Diagnosis and Treatment Product
Table 84. Pfizer Inc Recent Developments/Updates
Table 85. Abbvie Inc Company Information
Table 86. Abbvie Inc Description and Business Overview
Table 87. Abbvie Inc Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Abbvie Inc Overactive Bladder Diagnosis and Treatment Product
Table 89. Abbvie Inc Recent Developments/Updates
Table 90. Viatris Inc Company Information
Table 91. Viatris Inc Description and Business Overview
Table 92. Viatris Inc Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Viatris Inc Overactive Bladder Diagnosis and Treatment Product
Table 94. Viatris Inc Recent Developments/Updates
Table 95. Hisamitsu Pharmaceutical Company Information
Table 96. Hisamitsu Pharmaceutical Description and Business Overview
Table 97. Hisamitsu Pharmaceutical Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Hisamitsu Pharmaceutical Overactive Bladder Diagnosis and Treatment Product
Table 99. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 100. Johnson & Johnson Services Company Information
Table 101. Johnson & Johnson Services Description and Business Overview
Table 102. Johnson & Johnson Services Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Johnson & Johnson Services Overactive Bladder Diagnosis and Treatment Product
Table 104. Johnson & Johnson Services Recent Developments/Updates
Table 105. Endo Pharmaceuticals Company Information
Table 106. Endo Pharmaceuticals Description and Business Overview
Table 107. Endo Pharmaceuticals Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Endo Pharmaceuticals Overactive Bladder Diagnosis and Treatment Product
Table 109. Endo Pharmaceuticals Recent Developments/Updates
Table 110. Lupin Company Information
Table 111. Lupin Description and Business Overview
Table 112. Lupin Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Lupin Overactive Bladder Diagnosis and Treatment Product
Table 114. Lupin Recent Developments/Updates
Table 115. KYORIN Pharmaceutical Company Information
Table 116. KYORIN Pharmaceutical Description and Business Overview
Table 117. KYORIN Pharmaceutical Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. KYORIN Pharmaceutical Overactive Bladder Diagnosis and Treatment Product
Table 119. KYORIN Pharmaceutical Recent Developments/Updates
Table 120. Amneal Pharmaceuticals Company Information
Table 121. Amneal Pharmaceuticals Description and Business Overview
Table 122. Amneal Pharmaceuticals Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Amneal Pharmaceuticals Overactive Bladder Diagnosis and Treatment Product
Table 124. Amneal Pharmaceuticals Recent Developments/Updates
Table 125. Sun Pharmaceutical Industries Company Information
Table 126. Sun Pharmaceutical Industries Description and Business Overview
Table 127. Sun Pharmaceutical Industries Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Sun Pharmaceutical Industries Overactive Bladder Diagnosis and Treatment Product
Table 129. Sun Pharmaceutical Industries Recent Developments/Updates
Table 130. Glenmark Company Information
Table 131. Glenmark Description and Business Overview
Table 132. Glenmark Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Glenmark Overactive Bladder Diagnosis and Treatment Product
Table 134. Glenmark Recent Developments/Updates
Table 135. Macleods Pharmaceuticals Company Information
Table 136. Macleods Pharmaceuticals Description and Business Overview
Table 137. Macleods Pharmaceuticals Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Macleods Pharmaceuticals Overactive Bladder Diagnosis and Treatment Product
Table 139. Macleods Pharmaceuticals Recent Developments/Updates
Table 140. Medtronic Company Information
Table 141. Medtronic Description and Business Overview
Table 142. Medtronic Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Medtronic Overactive Bladder Diagnosis and Treatment Product
Table 144. Medtronic Recent Developments/Updates
Table 145. Ajanta Pharma Company Information
Table 146. Ajanta Pharma Description and Business Overview
Table 147. Ajanta Pharma Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Ajanta Pharma Overactive Bladder Diagnosis and Treatment Product
Table 149. Ajanta Pharma Recent Developments/Updates
Table 150. Granules India Company Information
Table 151. Granules India Description and Business Overview
Table 152. Granules India Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Granules India Overactive Bladder Diagnosis and Treatment Product
Table 154. Granules India Recent Developments/Updates
Table 155. Urovant Sciences Company Information
Table 156. Urovant Sciences Description and Business Overview
Table 157. Urovant Sciences Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Urovant Sciences Overactive Bladder Diagnosis and Treatment Product
Table 159. Urovant Sciences Recent Developments/Updates
Table 160. Apotex Inc. Company Information
Table 161. Apotex Inc. Description and Business Overview
Table 162. Apotex Inc. Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Apotex Inc. Overactive Bladder Diagnosis and Treatment Product
Table 164. Apotex Inc. Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Overactive Bladder Diagnosis and Treatment Distributors List
Table 168. Overactive Bladder Diagnosis and Treatment Customers List
Table 169. Overactive Bladder Diagnosis and Treatment Market Trends
Table 170. Overactive Bladder Diagnosis and Treatment Market Drivers
Table 171. Overactive Bladder Diagnosis and Treatment Market Challenges
Table 172. Overactive Bladder Diagnosis and Treatment Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of Overactive Bladder Diagnosis and Treatment
Figure 2. Global Overactive Bladder Diagnosis and Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Overactive Bladder Diagnosis and Treatment Market Share by Type: 2024 & 2031
Figure 4. Anticholinergics Product Picture
Figure 5. Mirabegron Product Picture
Figure 6. BOTOX Product Picture
Figure 7. Neuromodulation Product Picture
Figure 8. Others Product Picture
Figure 9. Global Overactive Bladder Diagnosis and Treatment Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Overactive Bladder Diagnosis and Treatment Market Share by Application: 2024 & 2031
Figure 11. Idiopathic Overactive Bladder
Figure 12. Neurogenic Overactive Bladder
Figure 13. Global Overactive Bladder Diagnosis and Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Overactive Bladder Diagnosis and Treatment Market Size (2020-2031) & (US$ Million)
Figure 15. Global Overactive Bladder Diagnosis and Treatment Sales (2020-2031) & (K Units)
Figure 16. Global Overactive Bladder Diagnosis and Treatment Average Price (US$/Unit) & (2020-2031)
Figure 17. Overactive Bladder Diagnosis and Treatment Report Years Considered
Figure 18. Overactive Bladder Diagnosis and Treatment Sales Share by Manufacturers in 2024
Figure 19. Global Overactive Bladder Diagnosis and Treatment Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Overactive Bladder Diagnosis and Treatment Players: Market Share by Revenue in Overactive Bladder Diagnosis and Treatment in 2024
Figure 21. Overactive Bladder Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Overactive Bladder Diagnosis and Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Overactive Bladder Diagnosis and Treatment Sales Market Share by Country (2020-2031)
Figure 24. North America Overactive Bladder Diagnosis and Treatment Revenue Market Share by Country (2020-2031)
Figure 25. United States Overactive Bladder Diagnosis and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Overactive Bladder Diagnosis and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Overactive Bladder Diagnosis and Treatment Sales Market Share by Country (2020-2031)
Figure 28. Europe Overactive Bladder Diagnosis and Treatment Revenue Market Share by Country (2020-2031)
Figure 29. Germany Overactive Bladder Diagnosis and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Overactive Bladder Diagnosis and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Overactive Bladder Diagnosis and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Overactive Bladder Diagnosis and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Overactive Bladder Diagnosis and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Overactive Bladder Diagnosis and Treatment Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Overactive Bladder Diagnosis and Treatment Revenue Market Share by Region (2020-2031)
Figure 36. China Overactive Bladder Diagnosis and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Overactive Bladder Diagnosis and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Overactive Bladder Diagnosis and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Overactive Bladder Diagnosis and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Overactive Bladder Diagnosis and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Overactive Bladder Diagnosis and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Overactive Bladder Diagnosis and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Overactive Bladder Diagnosis and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Overactive Bladder Diagnosis and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Overactive Bladder Diagnosis and Treatment Sales Market Share by Country (2020-2031)
Figure 46. Latin America Overactive Bladder Diagnosis and Treatment Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Overactive Bladder Diagnosis and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Overactive Bladder Diagnosis and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Overactive Bladder Diagnosis and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Overactive Bladder Diagnosis and Treatment Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Overactive Bladder Diagnosis and Treatment Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Overactive Bladder Diagnosis and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Overactive Bladder Diagnosis and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Overactive Bladder Diagnosis and Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Overactive Bladder Diagnosis and Treatment by Type (2020-2031)
Figure 56. Global Revenue Market Share of Overactive Bladder Diagnosis and Treatment by Type (2020-2031)
Figure 57. Global Overactive Bladder Diagnosis and Treatment Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Overactive Bladder Diagnosis and Treatment by Application (2020-2031)
Figure 59. Global Revenue Market Share of Overactive Bladder Diagnosis and Treatment by Application (2020-2031)
Figure 60. Global Overactive Bladder Diagnosis and Treatment Price (US$/Unit) by Application (2020-2031)
Figure 61. Overactive Bladder Diagnosis and Treatment Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
